Back to Research Home
HWKNHawkins Inc
Consumer Discretionary · Specialty Chemicals · Mid
$132.32−0.64%
As of 23 Oct 2026Mkt cap $2.6B
Stage 13
WAIT
Fundamentals
41.9/75
Technical
7.8/15
Independent
49.8/90
GCAE viewelevated earnings event risk blocks an independent BUY decision
Price
- 1M
- +4.5%
- 3M
- −5.7%
- 6M
- −22.5%
- 1Y
- −19.0%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 34.3xHist median 34.5x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 30.1x
- FCF yield
- 3.3%
Quality
- ROIC
- 12.7%
- Operating margin
- 11.3%
- FCF margin
- 7.9%
- Current ratio
- 2.2x
Growth
- Revenue growth
- +11.2%Latest FY YoY
- Revenue CAGR
- +8.8%
- EPS CAGR
- +12.5%
- FCF CAGR
- +56.6%
Capital
- Share-count trend
- −0.4%3Y annualised
- Net debt
- $258M1.8x OCF
Annual trend
- CAGR 2022–2026
- +8.8%
- Latest · 2026
- $1B
- YoY
- +11.2%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
elevated earnings event risk blocks an independent BUY decision
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-10-26
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- approaching-support
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded